Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Specific Immunotherapy in Ovarian Cancer: A Systematic Review Publisher Pubmed



Alipour S1 ; Zoghi S1 ; Khalili N1 ; Hirbodmobarakeh A1, 2, 3 ; Emens LA4 ; Rezaei N2, 3, 5
Authors

Source: Immunotherapy Published:2016


Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several approaches of active and passive immunotherapy for EOC have been studied. The aim of this systematic review was to assess the clinical efficacy of specific immunotherapy in patients with EOC. We found 4524 references in seven databases and we included ten controlled clinical trials with 2285 patients with EOC reporting five active immunotherapeutic agents and three passive immunotherapies. Meta-analysis of six studies showed that overall there was not any significant difference in overall survival and recurrence-free survival between patients undergoing specific immunotherapy and those in control group. Most of the studies we evaluated reported a positive outcome from treatment with specific immunotherapy, although this was not significant. © 2016 Future Medicine Ltd.
Related Docs
View other Related Docs
1. Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers, International Journal of Cancer Management (2016)
2. The Clinicopathologic Characteristics and 3-Year Survival Rates of Epithelial Ovarian Cancer in Iran During 2011-2017, International Journal of Women's Health and Reproduction Sciences (2019)
3. Uterine Involvement in Epithelial Ovarian Cancer and Its Risk Factors, Journal of Ovarian Research (2021)
Experts (# of related papers)
View all Related Experts
Azam Sadat Mousavi (5)
Nima Rezaei (4)
Other Related Docs
4. Does a Decrease in Ca-125 in Advanced Ovarian Cancer Following Neoadjuvant Chemotherapy Predict the Clinical Outcome of Patients? a Cross-Sectional Study, International Journal of Women's Health and Reproduction Sciences (2022)
5. The Role of Intraperitoneal Carboplatin As Consalidation Chemotherapy in Women With Ovarian Carcinoma: Report of Our Experience and Systematic Review, International Journal of Biomedical Science (2016)
6. Egfr Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells, Iranian Biomedical Journal (2020)
7. The Inhibitory Receptors Pd1, Tim3, and A2ar Are Highly Expressed During Mesocar T Cell Manufacturing in Advanced Human Epithelial Ovarian Cancer, Cancer Cell International (2023)
8. Clear Cell Carcinoma of the Ovary and Venous Thromboembolism: A Systematic Review and Meta-Analysis, Current Medical Research and Opinion (2023)
9. Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women With Ovarian Cancer, Indian Journal of Gynecologic Oncology (2024)
10. Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: Axl, Gas6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer, Iranian Journal of Public Health (2019)
11. Application of E75 Peptide Vaccine in Breast Cancer Patients: A Systematic Review and Meta-Analysis, European Journal of Pharmacology (2018)
12. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
13. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
14. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
15. Prognostic Significance of Non-Coding Rnas Related to the Tumorigenic Epithelial-Mesenchymal Transition (Emt) Process Among Ovarian Cancer Patients: A Systematic Review and Meta-Analysis, Heliyon (2024)
16. Immunotherapy for Breast Cancer Treatment, Iranian Biomedical Journal (2021)
17. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
18. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
19. Renal Dysfunction in Individuals With Ovarian Cancer; a Review on Current Concepts, Journal of Renal Injury Prevention (2023)
20. Ovarian Cancer in the World: Epidemiology and Risk Factors, International Journal of Women's Health (2019)